Authors' response to 'aspirin dose for treatment of Kawasaki disease'

Arch Dis Child. 2015 Mar;100(3):300-1. doi: 10.1136/archdischild-2014-307798. Epub 2014 Nov 25.

Authors

Despina Eleftheriou¹, Michael Levin², Delane Shingadia³, Robert Tulloh⁴, Nigel Klein¹, Paul Brogan¹

Affiliations

¹ Institute of Child Health and Great Ormond Street, London.
² Paediatric Infectious Diseases Group, Division of Medicine, Imperial College London.
³ Great Ormond Street Hospital, London.
⁴ Department of Paediatric Cardiology, Bristol Royal Hospital for Children, Bristol, UK.

PMID: 25425602
DOI: 10.1136/archdischild-2014-307798

No abstract available

Publication types

Letter
Comment

MeSH terms

Adrenal Cortex Hormones / therapeutic use*
Humans
Immunoglobulins, Intravenous / therapeutic use*
Mucocutaneous Lymph Node Syndrome / therapy*

Substances

Adrenal Cortex Hormones
Immunoglobulins, Intravenous